Phase 1 Giant Cell Tumor Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor

NeoplasmsTenosynovial Giant Cell Tumor

Abbisko Therapeutics Co, Ltd276 enrolled17 locationsNCT04192344

Recruiting

Phase 1Phase 2

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Giant Cell Tumor of Bone

Tang Xiaodong45 enrolled1 locationNCT06647901